Cathay Biotech Inc. (688065.SS)
CNY 50.66
(0.36%)
CNY 50.66
(0.36%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 569.45 Million | 803.67 Million | 594.18 Million | 514.96 Million | 359.61 Million | -10.28 Million |
| Net Income | 366.52 Million | 612.65 Million | 646.68 Million | 457.34 Million | 478.88 Million | 466.29 Million |
| Depreciation & Amortization | 289.59 Million | 265.12 Million | 168.53 Million | 118.31 Million | 116.27 Million | 72.61 Million |
| Deferred income taxes | -70.59 Million | -36.07 Million | -16.91 Million | 4.74 Million | -17.56 Million | -10.11 Million |
| Stock-based compensation | 6.6 Million | 16.16 Million | 6.23 Million | 474.48 Thousand | 3.24 Million | - |
| Change in working capital | -99.44 Million | -73.88 Million | -212.14 Million | -77.96 Million | -226.66 Million | -527.77 Million |
| Other non-cash items | 770.66 Million | 19.69 Million | 1.78 Million | 12.04 Million | 5.45 Million | -21.42 Million |
| Investing Cash Flow | -2.1 Billion | -4.19 Billion | -126.25 Million | -1.19 Billion | -1.2 Billion | -587.6 Million |
| Investments in PPE | -1.56 Billion | -4.19 Billion | -1.47 Billion | -763.11 Million | -511.13 Million | -410.08 Million |
| Acquisitions | -405.85 Million | 6.14 Million | 1.85 Billion | 1.1 Billion | 2.51 Million | 1.5 Million |
| Investment purchases | -101.04 Million | - | -1.85 Billion | -5.87 Billion | -10 Million | -37.3 Million |
| Sales/Maturities of investments | - | - | 28.42 Million | 35.88 Million | 4.81 Million | 4.59 Million |
| Other Investing Activities | -30 Million | -5.99 Million | 1.32 Billion | 4.3 Billion | -692.9 Million | -146.32 Million |
| Financing Cash Flow | 285.7 Million | 403.87 Million | 2.98 Billion | 6.06 Billion | 1.05 Billion | 645.09 Million |
| Debt repayment | -647.25 Million | -740 Million | -55 Million | -300.24 Million | -390.47 Million | -77.07 Million |
| Dividends payments | -104.78 Million | -187.29 Million | -333.34 Million | -3.87 Million | -121.33 Million | -178.82 Million |
| Common Stock Repurchased | -31.52 Million | -94.66 Million | - | - | - | - |
| Common Stock Issuance | - | 94.66 Million | - | - | - | - |
| Other Financing Activities | -225.23 Million | 1.35 Billion | 3.38 Billion | 6.36 Billion | 1.56 Billion | 900.99 Million |
| Accounts receivables | -320.05 Million | 24.79 Million | -224.95 Million | -32.77 Million | 232.27 Million | -453.2 Million |
| Accounts payables | 133.65 Million | 355.46 Million | 310.02 Million | 40.52 Million | -7.35 Million | 278.87 Million |
| Inventory | 78.29 Million | -418.06 Million | -282.61 Million | -90.45 Million | -434.02 Million | -343.32 Million |
| Other working capital | 8.65 Million | -36.07 Million | -14.59 Million | 4.74 Million | -17.56 Million | -184.44 Million |
| Cash at beginning of period | 6.29 Billion | 9.15 Billion | 5.7 Billion | 331.21 Million | 129.21 Million | 76.99 Million |
| Cash at end of period | 5.39 Billion | 6.22 Billion | 9.15 Billion | 5.7 Billion | 331.21 Million | 129.21 Million |
| Capital Expenditure | -1.56 Billion | -4.19 Billion | -1.47 Billion | -763.11 Million | -511.13 Million | -410.08 Million |
| Effect of forex changes on cash | 40.22 Million | 59.98 Million | -9.18 Million | -2.82 Million | -1.32 Million | 5 Million |
| Net cash flow / Change in cash | -904.38 Million | -2.93 Billion | 3.44 Billion | 5.37 Billion | 201.99 Million | 52.21 Million |
| Free Cash Flow | -1 Billion | -3.39 Billion | -880.49 Million | -248.14 Million | -151.52 Million | -420.37 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 97.73 Million | 142.18 Million | 105.25 Million | 366.52 Million | 52.63 Million | 72.02 Million |
| Depreciation & Amortization | - | 81.15 Million | 81.15 Million | 289.59 Million | 76.05 Million | -133.5 Million |
| Deferred income taxes | - | - | - | -70.59 Million | - | 117.74 Million |
| Stock-based compensation | - | 3.35 Million | - | 6.6 Million | 6.6 Million | -8.09 Million |
| Change in working capital | - | 24.83 Million | - | -99.44 Million | -233.1 Million | 23.85 Million |
| Other non-cash items | 142.82 Million | 159.14 Million | 110.01 Million | 770.66 Million | 62.59 Million | 134.07 Million |
| Investing Cash Flow | -79.23 Million | -71.44 Million | -463.22 Million | -2.1 Billion | -793.98 Million | -443.53 Million |
| Investments in PPE | -79.27 Million | -101.44 Million | -463.22 Million | -1.56 Billion | -228.66 Million | -573 Million |
| Acquisitions | 46.19 Thousand | - | - | -405.85 Million | -535.32 Million | 129.47 Million |
| Investment purchases | - | - | - | -101.04 Million | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | 30 Million | - | -30 Million | -30 Million | 0.30 |
| Financing Cash Flow | -120.16 Million | -321.83 Million | 28.31 Million | 285.7 Million | 206.04 Million | -96.62 Million |
| Debt repayment | -201.96 Million | -167.69 Million | -92.1 Million | -647.25 Million | -271.78 Million | -125.12 Million |
| Dividends payments | - | -110.45 Million | -10.62 Million | -104.78 Million | -11.04 Million | -112.89 Million |
| Common Stock Repurchased | 17.92 Million | -17.92 Million | - | -31.52 Million | -31.52 Million | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 63.87 Million | -25.76 Million | 120.42 Million | -225.23 Million | 70.57 Million | 141.39 Million |
| Accounts receivables | - | -91.73 Million | - | -320.05 Million | -320.05 Million | 91.95 Million |
| Accounts payables | - | - | - | 133.65 Million | - | 8.09 Million |
| Inventory | - | 113.2 Million | - | 78.29 Million | 78.29 Million | -68.09 Million |
| Other working capital | - | 3.35 Million | - | 8.65 Million | 8.65 Million | -8.09 Million |
| Cash at beginning of period | 4.63 Billion | 4.98 Billion | 5.39 Billion | 6.29 Billion | 5.81 Billion | 5.91 Billion |
| Cash at end of period | 4.63 Billion | 4.63 Billion | 4.98 Billion | 5.39 Billion | 5.39 Billion | 5.57 Billion |
| Capital Expenditure | -79.27 Million | -101.44 Million | -463.22 Million | -1.56 Billion | -228.66 Million | -573 Million |
| Effect of forex changes on cash | - | 9.65 Million | 1.07 Million | 40.22 Million | -12.23 Million | -4.26 Million |
| Net cash flow / Change in cash | 2.22 Million | -352.84 Million | -402.45 Million | -904.38 Million | -429.71 Million | -338.32 Million |
| Free Cash Flow | 161.27 Million | 118.73 Million | -247.95 Million | -1 Billion | -189.48 Million | -366.9 Million |
000507
000935
002316
AVACF
002624
2255